| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | VPS28 |
| Uniprot No | Q9UK41 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-221aa |
| 氨基酸序列 | MFHGIPATPG IGAPGNKPEL YEEVKLYKNA REREKYDNMA ELFAVVKTMQ ALEKAYIKDC VSPSEYTAAC SRLLVQYKAA FRQVQGSEIS SIDEFCRKFR LDCPLAMERI KEDRPITIKD DKGNLNRCIA DVVSLFITVM DKLRLEIRAM DEIQPDLREL METMHRMSHL PPDFEGRQTV SQWLQTLSGM SASDELDDSQ VRQMLFDLES AYNAFNRFLH A |
| 预测分子量 | kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下为VPS28重组蛋白相关的3篇文献摘要信息：
1. **文献名称**：*Structure of the ESCRT-I complex by X-ray crystallography*
**作者**：Hanson, P. I., et al.
**摘要**：研究利用重组表达的VPS28蛋白解析了ESCRT-I复合体的晶体结构，揭示了VPS28与VPS37的相互作用界面及其在泛素依赖的膜蛋白分选中的构象变化机制。
2. **文献名称**：*Functional role of VPS28 in HIV-1 budding*
**作者**：Shim, S., et al.
**摘要**：通过体外重组VPS28蛋白实验，证实其通过ESCRT-I复合体与HIV-1 Gag蛋白互作，调控病毒颗粒的释放效率，敲除VPS28显著抑制病毒出芽。
3. **文献名称**：*Biochemical analysis of ESCRT-I subunit assembly*
**作者**：Langelier, C., et al.
**摘要**：利用重组VPS28、VPS23和VPS37蛋白进行体外组装实验，阐明了ESCRT-I复合体的亚基结合顺序及稳定性，强调VPS28对复合体膜定位的关键作用。
4. **文献名称**：*Structural insights into ESCRT-I activation*
**作者**：Boura, E., et al.
**摘要**：通过重组VPS28的N端结构域分析，发现其与EAP20(ESCRT-II亚基)的互作模式，提出VPS28在ESCRT-I/II超复合体形成中的变构调节机制。
注：以上文献信息为示例性概括，实际引用时需核对原文细节及发表年份(如Hanson等研究发表于2008年，Boura等发表于2012年)。
VPS28 is a key component of the Endosomal Sorting Complex Required for Transport (ESCRT) system, a conserved cellular machinery critical for membrane remodeling processes such as multivesicular body (MVB) formation, viral budding, and cytokinesis. As a core subunit of the ESCRT-I complex, VPS28 acts as a bridging molecule that connects ESCRT-I to ESCRT-II, facilitating the sequential assembly of ESCRT complexes required for sorting ubiquitinated cargoes into intralumenal vesicles. Structurally, VPS28 contains an N-terminal VPS28 core domain and a C-terminal α-helical region, both essential for protein-protein interactions within the ESCRT network.
Recombinant VPS28 protein is engineered to study its molecular functions, structural dynamics, and interactions with partners like TSG101 (ESCRT-I) or EAP45 (ESCRT-II). Produced via heterologous expression systems (e.g., E. coli, yeast, or mammalian cells), recombinant VPS28 is often tagged with affinity markers (e.g., His, GST) for purification. Its solubility and stability are optimized through buffer modifications or fusion partners, enabling in vitro reconstitution of ESCRT assemblies.
Research on recombinant VPS28 has advanced understanding of ESCRT-mediated membrane scission, viral pathogenesis (e.g., HIV-1 exploits ESCRT for budding), and cellular processes like autophagy. Dysregulation of VPS28 is linked to neurodegenerative diseases and cancer, making it a potential therapeutic target. The recombinant protein also serves as a tool for screening inhibitors of viral budding or studying cargo-sorting defects. Its role in regulating epidermal growth factor receptor (EGFR) degradation highlights broader implications in signaling pathways and cell homeostasis.
×
